By: Avery Mullen
Date: Jan. 18, 2024
The Halifax maker of “biofibres” is eyeing the medical research industry.
Halifax life sciences startup 3D BioFibR and collaborator PlantForm Corporation, headquartered in Toronto, are receiving $1.3 million from industry group Next Generation Manufacturing Canada, or NGen.
The money will fund efforts by the two companies to scale 3D BioFibR’s process for manufacturing biofibres — fibres that exist in nature and are used by humans, such as spider silk and collagen — with a particular focus on producing recombinant human collagen for the medical research market.
Scaling 3D BioFibR’s process will involve using PlantForm’s vivoXPRESS platform for creating biologics with the help of plants, rather than the more common approach of using mammalian cells.